Get the Stockscreener App
2.90
2.68%
-0.08
After Hours:
2.90
BiomX Inc stock is traded at $2.90, with a volume of 58,982.
It is down -2.68% in the last 24 hours and down -57.42% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$2.98
Open:
$3
24h Volume:
58,982
Relative Volume:
0.07
Market Cap:
$18.98M
Revenue:
-
Net Income/Loss:
$-36.20M
P/E Ratio:
-0.1215
EPS:
-23.8772
Net Cash Flow:
$-26.39M
1W Performance:
-12.12%
1M Performance:
-57.42%
6M Performance:
-73.68%
1Y Performance:
-72.74%
1-Day Range:
$2.85
$3.01
1-Week Range:
$2.81
$3.77
52-Week Range:
$1.5004
$14.71
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
2.90 | 19.50M | 0 | -36.20M | -26.39M | -23.88 |
VRTX
Vertex Pharmaceuticals Inc
|
443.92 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
775.53 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.07 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.25 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.19 | 33.72B | 5.36B | 287.73M | 924.18M | 2.5229 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Aug Swings: Can BiomX Inc stock double in the next yearStop Loss & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Guidance Update: Should I trade or invest in BiomX Inc2026 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Biotech Firm BiomX Enters Defense Market, Plans to Acquire DFSL | Business | Apr 2026 - Photonics Spectra
PHGE Technical Analysis | Trend, Signals & Chart Patterns | BIOMX INC (NYSEARCA:PHGE) - ChartMill
BiomX Secures Option to Acquire Defense Tech Company - TipRanks
BiomX enters agreement for option to acquire DFSL through Mandragola deal - Investing.com
BiomX Takes Option to Acquire DR. Frucht Systems With $5M Note, Equity and Warrants - TradingView
BiomX (PHGE) gets exclusive option on DFSL LADAR security business - Stock Titan
BiomX to acquire laser detection firm DFSL in defense pivot By Investing.com - Investing.com Australia
Biomx Obtains Option to Acquire Control of Is - Moomoo
BiomX obtains option to acquire control of Israeli laser-radar counter-drone system - marketscreener.com
BiomX to acquire laser detection firm DFSL in defense pivot - Investing.com
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System - The Manila Times
BiomX Inc. Enters Option Agreement to Acquire DFSL and Expand into Defense and Security Markets - Quiver Quantitative
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System - Benzinga
Laser-radar system with 99% accuracy pulls BiomX into drone defense - Stock Titan
Insider Sell: Can BiomX Inc stock outperform in a bear marketChart Signals & Community Consensus Trade Alerts - baoquankhu1.vn
BiomX appoints defense intelligence advisor for security pivot By Investing.com - Investing.com South Africa
BiomX appoints defense intelligence advisor for security pivot - Investing.com
BiomX Inc. Appoints Dr. Ehud Levi to Advisory Board - marketscreener.com
Biomx adds former Mossad deputy to advisory board - marketscreener.com
BiomX Inc. Appoints Dr. Ehud Levi to Advisory Board to Explore Strategic Opportunities in Defense and Counter-UAS Technologies - Quiver Quantitative
BiomX Adds Former Mossad Deputy to Advisory Board - marketscreener.com
Why a biotech hired a former Mossad deputy as it explores drone defense - stocktitan.net
BiomX Receives NYSE American Noncompliance Delisting Notice - The Globe and Mail
BiomX Inc. Receives NYSE American Notice for Stockholders’ Equity Deficiency and Discloses Going Concern Warning 1 - Minichart
BiomX receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
BiomX receives NYSE American non-compliance notice - MSN
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency - The Globe and Mail
BiomX Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BiomX (PHGE) hit by NYSE equity deficiency and auditor going concern - Stock Titan
BiomX (PHGE) Launches Subsidiary for Advanced Firefighting Solutions - GuruFocus
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations - The Globe and Mail
BiomX Inc. Launches New Subsidiary X Security & Defense LTD. to Address Growing Aerial Firefighting Needs in Israel - Quiver Quantitative
BiomX puts $3M into Israel unit for firefighting drone rights - Stock Titan
BiomX (NYSE: PHGE) proposes 2026 equity plan with 1.39M shares and 4% evergreen - Stock Titan
What is BiomX Incs 5 year growth outlookWeekly Earnings Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in Biomx Inc (PHGE) - Stock Titan
Market Catalysts: Will BiomX Inc outperform its industry peersInsider Selling & Precise Trade Entry Recommendations - baoquankhu1.vn
BiomX Details Financial Stabilization and Strategic Repositioning Plans - The Globe and Mail
BiomX amends warrants to one-year term, evaluates repositioning By Investing.com - Investing.com India
BiomX issues letter to shareholders - TipRanks
BiomX (PHGE) Restructures for Stronger Financial Future - GuruFocus
BiomX amends warrants to one-year term, evaluates repositioning - Investing.com
BiomX Cuts Warrant Strike to $1, Sets 2026 Expiry on 3.3M-Share Instrument - TradingView
BiomX (NYSE: PHGE) shortens warrant term and explores tech pivot - stocktitan.net
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
1.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):